A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants

NCT00628303 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study never officially opened for enrollment

Conditions

Wheezing

Interventions

BIOLOGICAL: Motavizumab
OTHER: Placebo

Sponsor

MedImmune LLC